If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
INTERVENTIONAL
CARDIOLOGY
ISSN 2053-423X July 2014 • emjreviews.com
INSIDE
Review of
EuroPCR 2014
Paris, France
CONTENTS
EDITORIAL BOARD................................................................................................................................. 4
CONGRESS REVIEW............................................................................................................................... 8
• Review of EuroPCR: The Official Meeting of the European Association of
Percutaneous Cardiovascular Interventions (EAPCI) held in Paris, France,
20th-23rd May 2014
PERCUTANEOUS RECANALISATION OF CORONARY ARTERY CHRONIC TOTAL
OCCLUSIONS: A 2014 UPDATE.............................................................................................................. 28
• Dimitri Karmpaliot
INTERVENTIONAL CARDIOLOGY ISSN 2053-423X
CONTENTS EDITORIAL BOARD.......................
INTERVENTIONAL CARDIOLOGY CORONARY ARTERY BIFU
Editorial Board Interventional Cardiology Edit
Welcome It is a pleasure to welcome you to the se
SUBSCRIBE TO THE EMJ NEWSLETTER www.news.emjre
Foreword Prof Ran Kornowski Professor of Cardiova
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
Welcome to the European Medical Journal review of
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
Transcatheter Mitral Valve for the treatment of m
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
Salute to advancing technology TECHNOLOGICAL
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
Transcatheter aortic heart valve generating beats
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
Angioplasty balloon reaches stratosphere STATE-O
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
One big step for mitral valve technology
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
No fear renal denervation is here “We believ
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
Critical cardiac conundrums resolved by FFR FRA
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
Balloons: the answer to TAVI BALLOON-EXPANDABLE
EUROPCR ANNUAL CONGRESS 2014 LE PALAIS DES CONGRÈ
WORLD’S FIRST TAVI CE APPRO
PERCUTANEOUS RECANALISATION OF CORONARY ARTER
higher than historical comparisons, with a
CTO PCI Prognostic Impact A recently published
Dual Catheter Angiography No
AB CD Figure 2: (A
AB CD EF
Of note, use of the sub-intimal tracking a
Table 1 continued. Study DES Type Longest Fo
Table 2: Results of prospective studies with drug
a persistently ischemic zone. Catheter Cardio
CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTI
score 0 flow, with an estimated duration of at lea
Table 1: Mortality in STEMI patients undergoing p
had higher median levels of maximal myocardial- b
IRA after successful primary PCI. 300 patie
2012;5(1):147-54. 23. Conde-Vela C et al. Cardiog
RECENT ADVANCES IN SURGICAL AND PERCUTANEOUS
relevant MR are poor surgical candidates.7 It is
AB Figure 1: A) Implementation of extracorp
In 50%, reduction of MR by ≥1 Grade was noted at
Interventional Edge-to-Edge Repair Technique The
male, logEuroSCORE I 25[16-43]%) from our ce
Even more recently, very early clinical experienc
Review. 2011;6:170-2. 28 Feldman T et al. Percuta
TRANSCATHETER AORTIC VALVE IMPLANTATION: RE
TAVI Non-surgical, percutaneous treatment of pati
ABCDEFG Figure 2: Most recent CE-approved trans
Table 2: Overview of current available data of va
of the Medtronic Engager™ for transapical TAVI.31
Figure 4: Implantation of CoreValve™, guided by a
fibrillation without anticoagulant therapy, suffer
TAVI (46%), 25% with the crossing of the aortic v
20. Makkar RR et al. Transcatheter aortic-va
Heart Valve Dis. 2011;20(1):83-90. 61. Cribier A.
CORONARY BIFURCATION DISEASE AND BIFURCATION
Sanborn Type I Type II Type III Type IV Lefevre
the proximal segment size (suffix S, for small),
M Main prox. first A
Table 1: Published randomised controlled trials i
compared with the CABG cohort (14.5% versus
Corporation; Natick, MA), Antares® Coronar
Recently, bioresorbable vascular scaffold (BV
post-dilation or KB inflation. In addition, high-s
outcomes. BVS represents the last frontiers in th
intervention using paclitaxel-eluting stent
CORONARY ARTERY BIFURCATION LESIONS: A REVIEW OF
0,1 MB (Distal) MB SB (Proximal)
against provisional stenting in a randomised tria
M Main prox. first A
provisional SB stenting. Clinical outcome
analyses of randomised trials. In a substudy of t
Stent apposition can also be assessed by t
British Bifurcation Coronary Study. Circ Cardiova
CURRENT STATUS AND FUTURE PERSPECTIVES ON DRUG-
rigidity of the stent may alter the pulsatile pro
elevation myocardial infarctions (MI). The m
low neointimal hyperplasia. At 1-year follow-up,
Drug-Eluting BRS Under Preclinical Investigation
Table 2: Main bioresorbable vascular scaffold cli
Double stent technique (T-stent suggested) P
1.1 mm (crimped BVS) 0.3 mm (crimpe
REFERENCES 1. Grüntzig AR et al. Nonoperati
consecutive all-comers: Rationale and study de
BIORESORBABLE SCAFFOLDS FOR CARDIOVASCULAR
Table 1: Definitions of biodegradable, bioabsorbab
recruitment of specific cell types via chemotaxis.
Table 2: Bioresorbable polymers and their degrada
poly-3-hydroxybutyrate (P3HB), copolymers o
growth factors, or drugs.76-78 The most bro
implants.102 However, cellular infiltration is spa
degradation of aliphatic polyesters. Die Angewand
hybrid model for collagen-based tissue
NEW GENERATIONS OF DRUG-ELUTING STEN
Table 1: Overview of first, second, and third-gene
Table 1 continued. Series Platform Coatin
A recent meta-analysis13 compared the short-term
significant inflammatory response.27-31 The efficac
polymer, and the drug. Nonetheless, however
the Netherlands. 34. Ormiston JA et al. A bioabso
CORONARY STENT EVOLUTION – FROM
in mind, newer alloys, thinner struts, better rad
AB Mean Neointimal Thickness (mm2) CD 1.2 1
A Fracture I II
by DES. In patients within 30 days after
Patent Intermediate (<50%
In a network meta-analysis by Palmerini et al.,45
CoCr-EES struts PES struts
Pathologic Finding Preclinical experience Preclin
N Engl J Med. 2003;349(14):1315-23. 20. Stone GW
REVIEW: TRANSCATHETER AORTIC VAL
Access sheath size ranges from 14 F up to 24 F fo
further evidence of which therapeutic option is b
Sapien XT™ Sapien 3™ CoreValve
Table 2: Current and new devices and their respec
Clinical results with the first gen
ahead of print]. 7. Mack MJ et al. Outcomes follo
WHAT’S NEW Closed heart surgery: a proven success
INTERVENTIONAL CARDIOLOGY Non-invasive surgery a
WHAT’S NEW Mini-VADs to replace LVADs in heart fa
INTERVENTIONAL CARDIOLOGY Small patients, big ben
WHAT’S NEW Burning hearts to treat atrial fibrilla
INTERVENTIONAL CARDIOLOGY Anticoagulation denied
WHAT’S NEW Stents: ‘til death do us part? INNOVAT
Click for simulator features Teamwork Enhances
Featured Suppliers Interventional Cardiology Re
From a host of fifteen therapeutic areas, EUROPEAN
Buyer’s Guide Exhibitors • ABBOTT VASCULAR INTE
Interventional Cardiology • KEYSTONE HEART
UPCOMING EVENTS Transcatheter Cardiovascular The
INTERVENTIONAL CARDIOLOGY Left Atrial Appendage
SUBSCRIBE TO RECEIVE THE LATEST CATIONS PUBLI